Process Modifications. JBI may make Process Modifications to any 214 Immunotherapeutic or Permitted Derivative Immunotherapeutic independently of Aduro, and without Aduro’s consent. Any Process Modifications developed independently by Aduro shall constitute Aduro Intellectual Property and will be disclosed to JBI by Aduro.
Appears in 1 contract
Sources: Research and License Agreement (Aduro Biotech, Inc.)
Process Modifications. JBI may make Process Modifications to any 214 741 Immunotherapeutic or Permitted Derivative Immunotherapeutic independently of Aduro, and without Aduro’s consent. Any Process Modifications developed independently by Aduro shall constitute Aduro Intellectual Property and will be disclosed to JBI by Aduro.
Appears in 1 contract
Sources: Research and License Agreement (Aduro Biotech, Inc.)